PharMerica, a major player in the long-term care pharmacy industry, and its subsidiary Amerita’s Specialty Infusion Services (Amerita) are entangled in class action lawsuits following a significant data breach. The breach was announced via a notification letter sent out to patients on September 5, 2023.
Both entities reportedly identified suspicious activity in their networks and accordingly launched a forensic investigation, which confirmed malicious involvement. An unidentified threat actor had managed to compromise their systems around early March 2023, jeopardizing the sensitive data of an estimated 5.8 million individuals.
The ramifications of this breach are extensive, considering the vast number of people potentially impacted and the potential ripple effects. This breach underscores the need for robust cybersecurity measures, particularly for businesses that handle and store large volumes of crucial patient data.
For more details about the class action lawsuits against PharMerica and Amerita, you can visit JD Supra’s coverage of the data privacy and security breach.